These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 19956913)
1. Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study. Molinari C; Iorio P; Medri L; Ballardini M; Guiducci G; Cremonini AM; Cerasoli S; Riccioni L; Faedi M; Mariani GA; Zoli W; Silvestrini R; Calistri D Int J Mol Med; 2010 Jan; 25(1):145-51. PubMed ID: 19956913 [TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
4. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Kitange G; Misra A; Law M; Passe S; Kollmeyer TM; Maurer M; Ballman K; Feuerstein BG; Jenkins RB Genes Chromosomes Cancer; 2005 Jan; 42(1):68-77. PubMed ID: 15472895 [TBL] [Abstract][Full Text] [Related]
5. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas. Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632 [TBL] [Abstract][Full Text] [Related]
6. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807 [TBL] [Abstract][Full Text] [Related]
7. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Gadji M; Fortin D; Tsanaclis AM; Drouin R Cancer Genet Cytogenet; 2009 Oct; 194(1):12-22. PubMed ID: 19737649 [TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour]. Born PW; Broholm H; Laursen H Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240 [TBL] [Abstract][Full Text] [Related]
9. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. van den Bent MJ; Looijenga LH; Langenberg K; Dinjens W; Graveland W; Uytdewilligen L; Sillevis Smitt PA; Jenkins RB; Kros JM Cancer; 2003 Mar; 97(5):1276-84. PubMed ID: 12599236 [TBL] [Abstract][Full Text] [Related]
10. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens. Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068 [TBL] [Abstract][Full Text] [Related]
11. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity. Franco-Hernández C; Martínez-Glez V; de Campos JM; Isla A; Vaquero J; Gutiérrez M; Casartelli C; Rey JA Cancer Genet Cytogenet; 2009 Apr; 190(2):93-6. PubMed ID: 19380026 [TBL] [Abstract][Full Text] [Related]
12. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Hashimoto N; Murakami M; Takahashi Y; Fujimoto M; Inazawa J; Mineura K Cancer; 2003 May; 97(9):2254-61. PubMed ID: 12712480 [TBL] [Abstract][Full Text] [Related]
13. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas]. Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907 [TBL] [Abstract][Full Text] [Related]
14. Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions. Sonabend AM; Lesniak MS Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S25-32. PubMed ID: 16274268 [TBL] [Abstract][Full Text] [Related]
15. Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. Griffin CA; Burger P; Morsberger L; Yonescu R; Swierczynski S; Weingart JD; Murphy KM J Neuropathol Exp Neurol; 2006 Oct; 65(10):988-94. PubMed ID: 17021403 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas. Li J; Miao N; Liu M; Cui W; Liu X; Li X; Shi X; Qing S; Ma Y; Zhang W; Biekemituofu H Int J Clin Exp Pathol; 2014; 7(12):8609-15. PubMed ID: 25674225 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors. Scheie D; Andresen PA; Cvancarova M; Bø AS; Helseth E; Skullerud K; Beiske K Am J Surg Pathol; 2006 Jul; 30(7):828-37. PubMed ID: 16819324 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles associated with treatment response in oligodendrogliomas. French PJ; Swagemakers SM; Nagel JH; Kouwenhoven MC; Brouwer E; van der Spek P; Luider TM; Kros JM; van den Bent MJ; Sillevis Smitt PA Cancer Res; 2005 Dec; 65(24):11335-44. PubMed ID: 16357140 [TBL] [Abstract][Full Text] [Related]
19. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779 [TBL] [Abstract][Full Text] [Related]
20. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]